Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
KO-947
i
Other names:
KO-947, ARS-947
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Araxes Pharma, Kura Oncology
Drug class:
ERK inhibitor
Related drugs:
‹
SCH772984 (11)
dordaviprone (5)
AEZS-129 (1)
AEZS-134 (1)
CC-90003 (0)
bezisterim (0)
RG7842 (0)
SCH772984 (11)
dordaviprone (5)
AEZS-129 (1)
AEZS-134 (1)
CC-90003 (0)
bezisterim (0)
RG7842 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
NRAS mutation
Non Small Cell Lung Cancer
NRAS mutation
Non Small Cell Lung Cancer
KO-947
Sensitive: C2 – Inclusion Criteria
KO-947
Sensitive
:
C2
KO-947
Sensitive: C2 – Inclusion Criteria
KO-947
Sensitive
:
C2
NRAS mutation
Melanoma
NRAS mutation
Melanoma
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
NRAS mutation
Pancreatic Cancer
NRAS mutation
Pancreatic Cancer
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
KO-947
Sensitive: D – Preclinical
KO-947
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.